Business Combination (Tables)

12 Months Ended

Dec. 31, 2016

Schedule of Fair Values of Assets Acquired and Liabilities Assumed

The fair values of the assets acquired and liabilities assumed are as follows (in thousands):

	Total
Cash	$	596
Accounts receivable		1,608
Prepaid and other assets		1,092
Inventory		9,636
Property, plant and equipment		1,057
Intangible assets		31,560
Goodwill		16,922
Deferred tax liability		(8,598	)
Assumed liabilities		(19,799	)
Total preliminary acquisition consideration	$	34,074

Schedule of Noncontrolling Interests

Noncontrolling interest as of December 31, 2016 was as follows (in thousands):

	Total
Noncontrolling interest at January 1, 2016	$	—
Noncontrolling interest of acquired entity		634
Foreign currency effect		(68	)
Loss attributable to noncontrolling interest		(287	)
Noncontrolling interest at December 31, 2016	$	279

Summary of Identified Intangible Assets Acquired at Acquisition Date

The following table presents details of the identified intangible assets acquired at the acquisition date (in thousands):

	Estimated Fair Value		Estimated Useful Life (Years)
Customer relationships	$	12,650		15
Developed technology		11,650		10
Acquired in-process technology		4,510		15
Trademarks		2,260		15
Acquired contracts		490		2
Total	$	31,560

Schedule of Pro Forma Results of Operations

The following table presents pro forma results of operations and gives effect to the Allenex transaction as if the transaction had been consummated on January 1, 2015. The unaudited pro forma results of operations have been prepared for comparative purposes only and are not necessarily indicative of what would have occurred had the business combination been completed at the beginning of the period or of the results that may occur in the future. Furthermore, the pro forma financial information does not reflect the impact of any reorganization or operating efficiencies resulting from combining the two companies (in thousands).

	Years Ended December 31,
	2016			2015
Revenue:
Testing revenue	$	29,681		$	27,881
Product revenue		15,101			15,957
Other revenue	407				578
Total revenue	$	45,189		$	44,416
Net loss	$	(32,319	)	$	(17,050	)

ImmuMetrix, Inc. [Member]

Schedule of Pro Forma Results of Operations

The following table presents pro forma results of operations and gives effect to the IMX transaction as if the transaction had been consummated on January 1, 2013. The unaudited pro forma results of operations have been prepared for comparative purposes only and are not necessarily indicative of what would have occurred had the business combination been completed at the beginning of the period or of the results that may occur in the future. Furthermore, the pro forma financial information does not reflect the impact of any reorganization or operating efficiencies resulting from combining the two companies (in thousands).

	Year Ended December 31,
	2014			2013
Net revenue	$	27,306		$	22,098
Net loss	$	(1,080	)	$	(3,768	)